Plasma levels of IL-6 are known to be increased in patients with stable COPD compared to controls [51], remain elevated for a period, and may contribute to the increased risk of depression and mortality associated with COPD [52–54]. The gene discussed is IL6; the disease is chronic obstructive pulmonary disease.